<p>Density plots (smoothed histograms) of the distributions of MAFs for two HNSCCs. The horizontal-axis position of each circle represents the MAF for a tumor-specific mutated locus in the indicated tumor sample, for loci having MAFs no lower than 0.075: left, 117 loci; right, 106 loci. For each tumor, the median and the MAD of its MAFs are indicated; each tumor MATH value is the percentage ratio of its MAD to its median. The vertical density axis is scaled so that the area under the smoothed curve equals 1; a high peak density value indicates a sharp peak. MAFs of mutated loci in the high-heterogeneity tumor (right panel) show a lower median and higher MAD than those in the low-heterogeneity tumor (left panel), even though the total number...
<p><b>Copyright information:</b></p><p>Taken from "Genomic imbalances in 5918 malignant epithelial t...
<p>This figure illustrates the number of DM genes in the datasets for all five cancer types. The x-a...
<p>(A) compares the prevalence with which mutations from a specific cancer type fall within signific...
<p>Each boxplot shows the MAFs (from 0 to 1) of somatic SNVs found in an individual sample along wit...
A) Number of mutations (left panel) and number of clones (right panel) in tumor types and subtypes w...
<p><b>A.</b> Mutation spectrum of tumor-specific and non-tumor-specific variants are shown. <b>B.</b...
<p>Acceptable (<i>A</i>) and not acceptable (<i>NA</i>) tumor specimens with mutated (MUT) or wild-t...
<p>A) Heatmap of number of variants per tumour group. On the y-axis the different primary tumour sit...
<p>On the left the three peaks represent kernel distribution density plots of the frequencies of som...
<p>Boxplots show the CNA frequency distributions among tumor samples in 10 randomly selected cancer ...
<p>Distribution of the number of mutations according to mutational signatures in HR+/HER2− metastati...
<p>(a) A circos plot of tumor genome RMS2110 (before normal cell contamination correction). Gene sym...
These cases were selected because they are representative of most tumors in our database.<p><b>Copyr...
<p>(a) Cross-sample variability of methylation (Intra-tumour heterogeneity) and IGV are calculated i...
<p><i>(A–C)</i> Representative examples of relative DNA content estimates from mBAF data for allelic...
<p><b>Copyright information:</b></p><p>Taken from "Genomic imbalances in 5918 malignant epithelial t...
<p>This figure illustrates the number of DM genes in the datasets for all five cancer types. The x-a...
<p>(A) compares the prevalence with which mutations from a specific cancer type fall within signific...
<p>Each boxplot shows the MAFs (from 0 to 1) of somatic SNVs found in an individual sample along wit...
A) Number of mutations (left panel) and number of clones (right panel) in tumor types and subtypes w...
<p><b>A.</b> Mutation spectrum of tumor-specific and non-tumor-specific variants are shown. <b>B.</b...
<p>Acceptable (<i>A</i>) and not acceptable (<i>NA</i>) tumor specimens with mutated (MUT) or wild-t...
<p>A) Heatmap of number of variants per tumour group. On the y-axis the different primary tumour sit...
<p>On the left the three peaks represent kernel distribution density plots of the frequencies of som...
<p>Boxplots show the CNA frequency distributions among tumor samples in 10 randomly selected cancer ...
<p>Distribution of the number of mutations according to mutational signatures in HR+/HER2− metastati...
<p>(a) A circos plot of tumor genome RMS2110 (before normal cell contamination correction). Gene sym...
These cases were selected because they are representative of most tumors in our database.<p><b>Copyr...
<p>(a) Cross-sample variability of methylation (Intra-tumour heterogeneity) and IGV are calculated i...
<p><i>(A–C)</i> Representative examples of relative DNA content estimates from mBAF data for allelic...
<p><b>Copyright information:</b></p><p>Taken from "Genomic imbalances in 5918 malignant epithelial t...
<p>This figure illustrates the number of DM genes in the datasets for all five cancer types. The x-a...
<p>(A) compares the prevalence with which mutations from a specific cancer type fall within signific...